These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12849986)

  • 21. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.
    Gilmore TD
    Oncogene; 1999 Nov; 18(49):6925-37. PubMed ID: 10602467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a non-alpha-helical DNA-binding motif in the Rel homology region.
    Liu J; Sodeoka M; Lane WS; Verdine GL
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):908-12. PubMed ID: 8302865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
    J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
    Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
    J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
    White DW; Gilmore TD
    Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.
    Ishikawa H; Asano M; Kanda T; Kumar S; Gélinas C; Ito Y
    Oncogene; 1993 Nov; 8(11):2889-96. PubMed ID: 8414493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone-dependent deoxyribonucleic acid looping between RUSH/SMARCA3 and Egr-1 mediates repression by c-Rel.
    Hewetson A; Chilton BS
    Mol Endocrinol; 2008 Apr; 22(4):813-22. PubMed ID: 18174357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.
    Chen FE; Huang DB; Chen YQ; Ghosh G
    Nature; 1998 Jan; 391(6665):410-3. PubMed ID: 9450761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The increased transcriptional response and translocation of a Rel/NF-κB homologue in scallop Chlamys farreri during the immune stimulation.
    Zhou Z; Wang M; Zhao J; Wang L; Gao Y; Zhang H; Liu R; Song L
    Fish Shellfish Immunol; 2013 May; 34(5):1209-15. PubMed ID: 23403154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal determinants of I kappa B alpha necessary for the cytoplasmic regulation of c-Rel.
    Luque I; Zong WX; Chen C; Gélinas C
    Oncogene; 2000 Feb; 19(9):1239-44. PubMed ID: 10713713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
    Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
    J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG ODN-mediated regulation of IL-12 p40 transcription.
    Takeshita F; Klinman DM
    Eur J Immunol; 2000 Jul; 30(7):1967-76. PubMed ID: 10940886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein.
    Glineur C; Davioud-Charvet E; Vandenbunder B
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):583-91. PubMed ID: 11085954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.